TheEdgeResearch
Home / Stocks / VRNO

Verano Holdings Corp (VRNO)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$3.17 ▼ -8.70%
Market Cap
$231.2M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
1.42
52-Wk Range
3.03-9.75
CEO
George Archos
Country
US
Currency
USD

Verano Holdings Corp operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Chicago, IL, US. The stock last traded at $3.17, down 8.70% on the session, giving a market capitalisation of $231.2M. On trailing twelve-month figures it carries a trailing P/E of -1.05, a net margin of -24.2%. Its beta of 1.42 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-1.05
Price / Sales
0.27
Price / Book
3.45
EV / EBITDA
3.35
Gross margin
46.7%
Operating margin
6.1%
Net margin
-24.2%
Return on equity
—
Debt / equity
0.73
Current ratio
3.64
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
3,800
IPO date
2021-02-17
Headquarters
Chicago, IL, US
About Verano Holdings Corp

Verano Holdings Corp. engages in the cannabis business in the United States. It is involved in the cultivation, processing, wholesale, and retail distribution of cannabis. The company also designs, builds, and operates cannabis dispensaries. It sells its products under the Encore, Avexia, MÜV, Savvy, Essence, BITS, HYPHEN, Swift Lifts, Verano, and Zen Leaf brand names to medical and adult use markets. The company is headquartered in Chicago, Illinois.

Comparable companies

Verano Holdings Corp is most often compared with the following Healthcare names:

AAWHBKUHCURLFGLASITHUFMRMDMSTHNUGSPLNHVREOF
More research on VRNO
VRNO technical analysis VRNO TheEdge Score Compare against peers
Open full interactive analysis & DCF →